Spots Global Cancer Trial Database for anaplastic
Every month we try and update this database with for anaplastic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer | NCT00389441 | Thyroid Neoplas... | AG-013736 | 18 Years - | Pfizer | |
| Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA | NCT01269853 | Glioblastoma Mu... Anaplastic Astr... | Bevacizumab Bevacizumab | 18 Years - | Northwell Health | |
| XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT05005728 | Metastatic Cast... | vudalimab + car... vudalimab + ola... vudalimab monot... vudalimab + doc... vudalimab + cab... | 18 Years - | Xencor, Inc. | |
| Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer | NCT00389441 | Thyroid Neoplas... | AG-013736 | 18 Years - | Pfizer | |
| Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | NCT00654238 | Metastatic Diff... Metastatic Poor... Metastatic Anap... Metastatic Medu... | sorafenib | 18 Years - | University of Pennsylvania | |
| Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma | NCT00883688 | Brain Cancer Pediatric Cance... | Bevacizumab Lapatinib | - 21 Years | M.D. Anderson Cancer Center | |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) | NCT00968240 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) | NCT00968240 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA | NCT01180816 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | NCT00654238 | Metastatic Diff... Metastatic Poor... Metastatic Anap... Metastatic Medu... | sorafenib | 18 Years - | University of Pennsylvania | |
| Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma | NCT01386710 | Glioblastoma Mu... Anaplastic Astr... | Bevacizumab and... Bevacizumab and... | 18 Years - | Northwell Health | |
| Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) | NCT00968240 | Glioblastoma Mu... Anaplastic Astr... | Super-Selective... | 18 Years - | Northwell Health | |
| Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | NCT00654238 | Metastatic Diff... Metastatic Poor... Metastatic Anap... Metastatic Medu... | sorafenib | 18 Years - | University of Pennsylvania | |
| XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT05005728 | Metastatic Cast... | vudalimab + car... vudalimab + ola... vudalimab monot... vudalimab + doc... vudalimab + cab... | 18 Years - | Xencor, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
